Ekert H, Waters K D, Jurk I H, Mobilia J, Loughnan P
Med J Aust. 1979 Dec 15;2(12):657-9.
The antinausea and antivomiting effects of delta-9-tetrahydrocannabinol (THC) in children receiving cancer chemotherapy were compared with those of metoclopramide syrup and prochlorperazine tablets in two double-blind studies. THC was found to be a significantly better antinausea and antivomiting agent, but not all patients obtained relief of nausea and vomiting with THC. In some patients, THC enhanced appetite during a course of chemotherapy. In two patients, a "high" associated with THC administrationwas reported. Drowsiness was reported significantly more frequently with THC.
在两项双盲研究中，对接受癌症化疗的儿童使用δ-9-四氢大麻酚（THC）的抗恶心和止吐效果与甲氧氯普胺糖浆和丙氯拉嗪片进行了比较。结果发现，THC是一种明显更好的抗恶心和止吐药物，但并非所有患者使用THC后恶心和呕吐都能得到缓解。在某些患者中，THC在化疗过程中增强了食欲。有两名患者报告出现了与使用THC相关的“兴奋感”。使用THC后嗜睡的报告明显更频繁。
